Explore 3 Stock Ideas & Industry Insights Download Free Report

MustGrow Biologics Corp.

Company price
0.39 CAD -0.02 ( 4.88%)
Last update at 2026-11-04T20:43:00Z
VOLUME
53557
Market Cap
34.57M

Momentum Score

…

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.36
Low
0.40
High
52 Week Price Range
0.49
Low
1.15
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

MustGrow Biologics Corp. develops biological crop inputs to reduce reliance on conventional agrochemicals. Growth drivers include rising demand for sustainable inputs, regulatory pressure on some pesticides, and advancement of its development-to-commercialization pipeline that may benefit from broader adoption. Investors may find the company attractive as it targets lower-residue agriculture.

Key risks are limited operating history and revenues, dependence on successful field results and regulatory approvals, competition from large agrochemical firms and other biologicals makers, and execution and financing risk to scale production and distribution.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.41
Dividend Yield
-
Revenue TTM
7.54M
Revenue Per Share
0.14
Gross Profit TTM
0.93M
Debt / Equity
-
ROE
-202.96%
Net Debt
-
ROCE
-202.97%
Diluted EPS TTM
-0.12

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -4.89M -0.68M -5.57M -3.06M -3.31M
Net income -4.89M -0.68M -5.57M -3.06M -3.31M
Selling general administrative 3.82M 3.68M 4.48M 2.08M 2.86M
Gross profit 0.30M 4.71M - - -
Operating income -5.11M -0.80M -5.69M -3.01M -3.37M
Interest expense - 0.00M 0.01M 0.05M 0.05M
Interest income 0.20M 0.21M 0.10M 0.00M -
Net interest income 0.20M 0.21M 0.09M -0.05M -0.05M
Total revenue 0.40M 4.71M 0.01M 0.01M 0.00M
Total operating expenses 5.51M 5.52M 5.69M 3.03M 3.37M
Cost of revenue 0.10M 0.00M - - -
Total other income expense net 0.02M -0.08M 0.03M -0.00M 0.11M
Net income from continuing ops -4.89M -0.68M -5.57M -3.06M -3.31M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 5.42M 6.94M 7.13M 9.70M 3.37M
Total liab 3.25M 1.35M 1.90M 1.25M 1.05M
Total stockholder equity 2.17M 5.58M 5.24M 8.46M 2.32M
Capital stock 25.33M 25.06M 24.03M 23.03M 14.14M
Retained earnings -28.17M -23.28M -22.60M -17.04M -13.97M
Cash 3.00M 6.82M 7.02M 9.62M 3.31M
Total current liabilities 2.90M 1.21M 1.54M 0.86M 0.35M
Short long term debt 0.39M 0.62M 0.40M 0.37M 0.21M
Total current assets 4.66M 6.94M 7.13M 9.70M 3.37M
Long term debt 0.12M 0.14M 0.36M 0.38M 0.70M
Inventory 1.43M - - - -
Accounts payable - - - - 0.14M
Non current assets total 0.76M 0.00M 0.00M 0.00M 0.00M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Net borrowings -0.24M - - - -
Total cash from financing activities -0.24M 0.10M 0.65M 8.72M 1.86M
Net income -4.89M -0.68M -5.57M -3.06M -3.31M
Change in cash -3.82M -0.20M -2.60M 6.31M -0.72M
Begin period cash flow 6.82M 7.02M 9.62M 3.31M 4.03M
End period cash flow 3.00M 6.82M 7.02M 9.62M 3.31M
Total cash from operating activities -3.58M -0.29M -3.26M -2.41M -2.58M
Issuance of capital stock - - 0.00M 6.59M 0.00M
Change to inventory -0.30M - - - -
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.11M -0.54M 0.60M 0.33M 0.01M
Stock based compensation 1.47M 0.93M 1.69M 0.27M 0.78M
Other non cash items -0.27M - 0.01M 0.05M 0.05M
Free cash flow -3.58M -0.29M -3.26M -2.41M -2.58M

Peer Comparison*

Sector: Basic Materials Industry: Agricultural Inputs

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MGRO
MustGrow Biologics Corp.
-0.02
4.88%
0.39 - - 4.59 12.32 4.39 -10.12
IFOS
Itafos Corp
0.14
7.11%
2.11 4.38 7.72 1.24 1.14 0.96 2.79

Profile*

MustGrow Biologics Corp.

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

201 1st Avenue South, Saskatoon, SK, Canada, S7K 1J5

306 668 2652

Name Title Year Born
Mr. Corey J. Giasson B.Sc., MBA Pres, CEO & Director 1978
Mr. Todd L. Lahti CA, CFA CFO & Corp. Sec. 1966
Mr. Colin Bletsky COO & Director NA
Mr. Corey J. Giasson B.Sc., MBA President, CEO & Director 1978
Mr. Todd L. Lahti CA, CFA CFO & Corporate Secretary 1966

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…